Close

BioLineRx (BLRX) Presents Underlying Mechanism of Action Data for BL-8040 at AACR 2016

April 19, 2016 9:15 AM EDT Send to a Friend
BioLineRx Ltd. (Nasdaq: BLRX) announced that detailed results from a study on the underlying mechanism of action of BL-8040, its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login